Estriol‐mediated neuroprotection in multiple sclerosis localized by voxel‐based morphometry

INTRODUCTION: Progressive gray matter (GM) atrophy is a hallmark of multiple sclerosis (MS). Cognitive impairment has been observed in 40%–70% of MS patients and has been linked to GM atrophy. In a phase 2 trial of estriol treatment in women with relapsing–remitting MS (RRMS), higher estriol levels...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Brain Behav
Hlavní autoři: MacKenzie‐Graham, Allan, Brook, Jenny, Kurth, Florian, Itoh, Yuichiro, Meyer, Cassandra, Montag, Michael J., Wang, He‐Jing, Elashoff, Robert, Voskuhl, Rhonda R.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6160650/
https://ncbi.nlm.nih.gov/pubmed/30144306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1086
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky